Policies: Prescription & Fake Medications
NATIONAL MEDICATION REGULATORS IN NORTH AMERICA
Below is a list of national regulators in NORTH AMERICA to help address fake medicines - Click on each one for more information:
Comprehensive List of National Regulators Worldwide:
Click Here for a list of regulatory authorities worldwide regarding matters of national approvals and drug import licences. This page is continuously developing. If you wish to correct or add to any information displayed below, please contact CRASH@Lshtm.ac.uk
Also Click Here for WHO website listing with similar instructions
The FDA, but with guns: How far should a little-known office go to track down counterfeit drugs?
A special agent posing as a venture capitalist from Texas was negotiating with two Turkish businessmen for pricey chemotherapy drugs that had been smuggled into the country. Listening in from the adjoining room were another special agent, a U.S. attorney, and a team of translators. Soon after the deal was sealed, the Turkish suspects left the Hilton, only to be surrounded by local police and federal agents wielding guns. But this wasn’t an FBI sting or DEA operation. The lead agent in that hotel room was Spencer Morrison, of the Food and Drug Administration’s Office of Criminal Investigations. Learn More.
FDA Counterfeit Medicine
Counterfeit medicine is fake medicine. It may be contaminated or contain the wrong or no active ingredient. They could have the right active ingredient but at the wrong dose. Counterfeit drugs are illegal and may be harmful to your health. FDA takes all reports of suspect counterfeits seriously and, in order to combat counterfeit medicines, is working with other agencies and the private sector to help protect the nation's drug supply from the threat of counterfeits. Learn More.
Counterfeit Drugs on the Rise
With an ever-increasing volume of shipments from mail order pharmacies among them, the sheer magnitude of inspection necessitates a lengthy process and battery of tests to verify the veracity of the pills, one that is both too time and resource-consuming for us to continue given an ever-escalating number of incidents. As it’s LSPediA’s core commitment to furthering best practices in pharmaceutical supply chain management and, ultimately patient care, we feel compelled to create this series to dive deeper into the true cost of counterfeit drugs and what we can do to counteract them. Learn More.
USA Governments ‘Underestimate’ Threat of Counterfeit Drugs: Study
Counterfeit drugs have ballooned into a $431 billion market since 2000, affecting nearly two billion people worldwide, but governments have underestimated the dangers they pose to unwitting patients, according to a report in the Review of Business & Finance Studies. Often hard even for licensed distributors to detect, fake medications have flooded markets of both developed and underdeveloped countries as a consequence of high medical costs, corruption, and weak or nonexistent legislative measures to contain them—and the threat is likely to get worse unless authorities develop “harsher sanctions.” Learn More.
FDA warns 465 websites selling unapproved opioids, drugs for cancer, HIV
The FDA sent warning letters this month to seven networks operating 465 websites that were selling potentially dangerous, unapproved versions of opioid, antiviral and oncology prescription drugs to U.S. consumers, according to a press release. Investigators also intercepted 626 packages at several major U.S. airports and prohibited 794 products from entering the country. Learn More.